Genomic Health Stock Price - GHDX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Genomic Health Inc GHDX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 69.76 0.00 0.00 0.00 69.76 05:59:44
Bid Price Ask Price Spread Spread % News
64.39 71.00 6.61 9.31% - -
Stock Trades Traded Volume Average Volume 52 Week Range
2 42 381,722 50.77 - 92.18
Last Trade Time Type Quantity Stock Price Currency
04:06:59 31 $ 67.45 USD

Genomic Health Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.60B 37.29M $ 25.68M 0.67 50.90 35.23M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 36.00 5.50%

more financials information »

Genomic Health News

Loading Messages....

Latest GHDX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GHDX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week68.4970.4467.468.3072333k1.271.85%
1 Month71.3873.45566.0869.4320344k-1.62-2.27%
3 Months56.377.555.7271.2787634k13.4623.91%
6 Months64.977.550.7765.2943514k4.867.49%
1 Year65.3392.1850.7768.6040461k4.436.78%
3 Years29.5292.1826.3756.6159272k40.24136.31%
5 Years30.6192.1820.0547.9641233k39.15127.90%

Genomic Health Description

Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States.

Your Recent History
Genomic He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.